Health Care/Hospital

Ascentage Pharma to Announce Results from Four Clinical Studies at 2021 ASCO Annual Meeting, with Data of Its Drug Candidates Including Lisaftoclax (APG-2575) to Be Released in Oral Presentations for the First Time

SUZHOU, China and ROCKVILLE, Md., April 21, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that results from four clin...

2021-04-21 08:38 2292

Clinical Trial Industry Veteran Paul Malan Joins Bioforum as Vice President of Biostatistics

NESS ZIONA, Israel, April 21, 2021 /PRNewswire/ -- Bioforum , a data-focused contract research organization (CRO) serving life sciences organizations worldwide, today announced thatPaul Malan has joined the company as Vice President of Biostatistics. In this new role,...

2021-04-21 06:00 1589

China Biologic Announces Completion of Going Private Transaction

BEIJING, April 20, 2021 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced the completion of its merger (the "Merger") with CBPO Group Limited ("Merger...

2021-04-21 04:30 4494

Park Systems, World Leading Atomic Force Microscopy Manufacturer Hits 1 Trillion KRW Mark at KOSDAQ

SANTA CLARA, Calif., April 21, 2021 /PRNewswire/ -- Park Systems, world leading manufacturer of Atomic Force Microscopes announced the companystock valuation exceeded1 Trillion KRW (almost $1 Billion USD) at the end of KOSDAQ on April 5, 2021.  Park Systems issued 1 million shares for its initial...

2021-04-21 03:58 1642

Havas Health & You Bolsters Cloud-Based Client Solutions by Becoming the First Global Content Partner within Veeva Systems' Content Partner Program

NEW YORK, April 20, 2021 /PRNewswire/ -- Digital health has reached record-breaking funding this past year. In 2018, the market was valued at$8.5 billion, and by 2025, it is expected to grow to more than $55 billion according to Global Market Insights. Officially in the era of digitized medicine,...

2021-04-20 21:30 1633

iHerb Opens Its Sixth Fulfillment Center in Hong Kong

PASADENA, Calif., April 20, 2021 /PRNewswire/ -- iHerb is pleased to announce the opening of its sixth fulfillment center. Located inHong Kong, it will be the company's second overseas and will serveMainland China, Hong Kong, Japan, Malaysia, Singapore, and Thailand. The fulfillment center will c...

2021-04-20 21:00 3271

Transcenta Received IND Clearance from US FDA for Initiating Phase I Clinical Trial for its Bi-functional Anti-PD-L1/TGF-β Antibody TST005

SUZHOU, China, April 20, 2021 /PRNewswire/ -- Transcenta Holding Limited (Transcenta), a clinical stage global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, today announced that it has received clearance of i...

2021-04-20 20:54 1010

Biovaxys And The World Ovarian Cancer Coalition Join Forces For May 8th, World Ovarian Cancer Day

VANCOUVER, BC and TORONTO, April 20, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys"), the world leader in haptenized antigen vaccines for antiviral and cancers applications, announced today its sponsorship of this year's World Ovarian Cancer Day, a ...

2021-04-20 20:00 3421

LimaCorporate Announces The First Surgery Of SMR Stemless Reverse Shoulder System In The IDE Study

SAN DANIELE DEL FRIULI, Italy, April 20, 2021 /PRNewswire/ -- LimaCorporate is proud to announce the first surgery performed in the SMR Stemless Reverse Shoulder System Investigational Device Exemption (IDE) study. This randomized, multi-center comparative clinical trial is currently evaluating t...

2021-04-20 20:00 1704

Mindray Unlocks Vast Patient Monitoring Potential with M-Connect Universally Connected Platform

SHENZHEN, China, April 20, 2021 /PRNewswire/ -- Mindray (SZSE: 300760), a leading global developer and provider of medical devices and integrated solutions, has launched its universally connected platform, M-Connect, which unlocks the potential of individual patient monitoring with an integrated ...

2021-04-20 15:00 3355

Holmusk continues ambitious US growth with NYC headquarters and expanded management team

NEW YORK, April 20, 2021 /PRNewswire/ -- Holmusk, a leading global data science and digital health company building the largest Real-World Evidence (RWE) platform for behavioral health, announced today the opening of its headquarters inNew York City and addition of three new members to its manage...

2021-04-20 14:00 1662

One Year After COVID-19 Global Lockdown, Medical Panel Discusses Pandemic Impact on Patients with Underlying Conditions and the Need to Prioritize Chronic Diseases in the Future

WASHINGTON, April 20, 2021 /PRNewswire/ -- On Wednesday, April 21st, 2021, from 8:00AM - 9:30AM EDT, the Business Council for International Understanding (BCIU) and Viatris (NASDAQ: VTRS) will co-host a virtual dialogue following the 2021 Spring Meetings of the World Bank Group and the Internatio...

2021-04-20 11:53 2452

Prenetics Signs Multi-million Dollar Collaboration with Oxford University for Advanced Molecular Diagnostics

* The collaboration is a 3-year joint effort by Prenetics R&D Team, Oxford University and Oxford Suzhou for Advanced Research (OSCAR) for Molecular Diagnostics * A new Prenetics Innovation Technology Centre is established for advanced molecular diagnostics * Collaboration follows successful...

2021-04-20 09:00 1684

AACR 2021-ImmVira presents the preclinical study results of MVR-T3011 via intravenous administration

SHENZHEN, China, April 19, 2021 /PRNewswire/ -- On April 15, 2021, ImmVira presents the preclinical study results of MVR-T3011 via intravenous administration through publication in a virtual poster at the AACR annual meeting. MVR-T3011 is a replication competent and genetically modified oncolyti...

2021-04-20 08:30 1464

3 International Cancer Researchers to Receive the 2021 Fondation ARC Léopold Griffuel Prize

PARIS, April 20, 2021 /PRNewswire/ -- Whilst the Fondation ARC Léopold Griffuel Prize is widely recognised today as one of the most prestigious European awards in the field of cancer research, many people are unaware of the story behind it. It is the story of Léopold and Alice Griffuel, a couple ...

2021-04-20 08:30 552

iMDsoft announces Dedalus as their Channel Partner in Australia and New Zealand for MetaVision Clinical Information System, iMDsoft's best of class product suite

BRISBANE, Australia, April 20, 2021 /PRNewswire/ -- iMDsoft Ltd. and Dedalus are pleased to announce their Channel Partner Agreement, authorizing Dedalus to distribute MetaVision licenses and services, and support customers inAustralia andNew Zealand (ANZ). Through its Channel Partner program, i...

2021-04-20 07:01 1506

Abbott's Fast, Reliable and Convenient COVID-19 Tests Help the Philippines Fight Infection Surge

- Philippines scales its testing capability with two Abbott tests – a quick, patient-friendly rapid antigen test and lab-based quantitative antibody test - The Abbott Panbio™ COVID-19 Antigen Rapid Test Device comes with an easy-to-use nasal swab to detect active coronavirus infections in as earl...

2021-04-20 06:00 4578

Terumo Blood and Cell Technologies and CSL Plasma Announce Collaboration to Deliver New Plasma Collection Platform

LAKEWOOD, Colo. and BOCA RATON, Fla., April 19, 2021 /PRNewswire/ -- Terumo Blood and Cell Technologies and CSL Plasma today announce a collaboration to deliver a new plasma collection platform at CSL Plasma U.S. collection centers. A clinical trial of the investigational plasmapheresis device ...

2021-04-20 05:00 2094

Himalaya Therapeutics Announces Appointment of Nicholas Desjardins as Chief Financial Officer

SAN DIEGO, April 20, 2021 /PRNewswire/ -- Himalaya Therapeutics ("Himalaya"), a clinical-stage biopharmaceutical company focused on development and commercialization inGreater China of a novel class of investigational antibody therapeutics for the treatment of solid tumor cancer, which are based ...

2021-04-20 01:42 1828

Sirtex Medical and BlackSwan Vascular, Inc. announce first patient enrolled in pivotal LAVA Study

LAVA clinical trial underway for potential first FDA-approved liquid embolic system for a peripheral vascular indication WOBURN, Mass., April 20, 2021 /PRNewswire/ -- Sirtex Medical (Sirtex), a leading manufacturer of targeted liver cancer therapies, and BlackSwan Vascular, Inc. (BlackSwan), a B...

2021-04-20 00:57 1269
1 ... 524525526527528529530 ... 807